excellent post Orange887 May 2018 16:56
First post here but have been following this share closely since the incredible rise in November 17. I felt compelled to reply to the absolute garbage posted by Daveavt to try and prevent his lies becoming accepted as the truth, which is clearly what he intends.
The November RNS that prompted the rise over 3 days from 1p to a 30p intraday high (closed at 17p) was prompted by PYC disclosing for the FIRST TIME that they had been working with Merck for a number of years on several projects. Prior to this announcement, PYC market cap was around �500k, and as the agreement with Merck was worth a minimum of �500k per annum, it was no surprise that the share price went crazy.
Since then, on 26th Jan and 9th Feb PYC have announced they have commenced projects for 35k and 70k with a major pharma and a global top 10 pharma, who are unnamed at present, in the same way that Merck was prior to their unveiling in November.
I�m not going to state my opinion of what would happen if either of these two pharma�s commit to a long term contact a la Merck, as apparently that would be ramping... However, I will state that PYC have a validated business model, do not obviously require funding, are working with two top 10 global pharma�s, and have a market cap of �3.9m.
Any argument as to whether the share price should be 3p, 4p 5p or less is irrelevant unless you are a short term trader or shorter. If you have a time horizon of >6months the potential upside here is far greater, and as such a 5% allocation in my portfolio is a no brainer.
Last bit for Daveavt, I will post this as a reply to every one of your negative comments until you stop your campaign of hate, it has gone on for far too long.